Technical Analysis for ODT - Odonate Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 19.12 0.79% 0.15
ODT closed up 3.55 percent on Tuesday, August 14, 2018, on 49 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Flat
See historical ODT trend table...

Date Alert Name Type % Chg
Aug 14 Wide Bands Range Expansion 0.79%
Aug 13 Stochastic Reached Oversold Weakness 4.37%
Aug 13 Wide Bands Range Expansion 4.37%
Aug 13 Oversold Stochastic Weakness 4.37%
Aug 10 1,2,3 Retracement Bearish Bearish Swing Setup 0.47%
Aug 10 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.47%
Aug 10 Inside Day Range Contraction 0.47%
Aug 10 Wide Bands Range Expansion 0.47%
Aug 10 Oversold Stochastic Weakness 0.47%
Aug 9 1,2,3 Retracement Bearish Bearish Swing Setup -0.78%

Older signals for ODT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
Basic chart:

Profile
  • Earnings date: 2018-08-02
Odonate Therapeutics LLC is a pharmaceutical company which is engaged in the development of therapeutics which improves and extend the lives of patients with cancer.
Is ODT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 30 Odonate Therapeutics beats by $0.07
Jul 30 Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018
Jun 8 Play the Best Sector of Summer With These ETFs & Stocks
Jun 6 Can The Uptrend Continue for Odonate Therapeutics (ODT)?
Jun 5 New Research: Key Drivers of Growth for Helen of Troy, Macro Bank, American Software, Shire plc, KB Financial Group, and Odonate Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
Jun 4 The Week Ahead: Apple's Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs
Jun 2 Tesetaxel, Administered Orally as a Single Agent, Results in 45% Confirmed Response Rate in Patients with HER2 Negative, Hormone Receptor Positive, Metastatic Breast Cancer
Jun 2 Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C.
May 31 Odonate Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
May 16 Odonate Therapeutics Announces Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
See more ODT news...
Indicators
Indicator Value
52 Week High 32.0
52 Week Low 15.15
Average Volume 37,649
200-Day Moving Average 0.0
50-Day Moving Average 23.0558
20-Day Moving Average 20.3895
10-Day Moving Average 19.042
Average True Range 1.3095
ADX 33.69
+DI 14.8262
-DI 20.548
Chandelier Exit (Long, 3 ATRs ) 20.5315
Chandelier Exit (Short, 3 ATRs ) 21.6785
Upper Bollinger Band 23.8402
Lower Bollinger Band 16.9388
Percent B (%b) 0.29
BandWidth 33.847814
MACD Line -1.2253
MACD Signal Line -1.1983
MACD Histogram -0.027
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.21
Resistance 3 (R3) 21.26 20.56 20.83
Resistance 2 (R2) 20.56 19.99 20.54 20.71
Resistance 1 (R1) 19.77 19.64 20.17 19.72 20.58
Pivot Point 19.07 19.07 19.27 19.05 19.07
Support 1 (S1) 18.28 18.50 18.68 18.23 17.36
Support 2 (S2) 17.58 18.15 17.56 17.23
Support 3 (S3) 16.79 17.58 17.11
Support 4 (S4) 16.74